In conditions like obesity and T2D, persistent low-grade inflammation disrupts the hepcidin–ferroportin cycle, contributing to iron misdistribution, functional iron deficiency, and anemia of chronic disease (ACD)/anemia of inflammation (AI) [205]. Here, HAMP is linked to obesity due to melanocortin 4 receptor deficiency.